UiPath
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
UiPath Inc. delivers a comprehensive automation ecosystem, specializing in Robotic Process Automation (RPA) solutions, with a significant presence in the United States, Romania, and Japan. The company...
Latest News
15 hours ago · zacks.com
Is Trending Stock UiPath, Inc. (PATH) a Buy Now?Recently, Zacks.com users have been paying close attention to UiPath (PATH). This makes it worthwhile to examine what the stock has in store.
6 days ago · zacks.com
UiPath (PATH) Declines More Than Market: Some Information for InvestorsUiPath (PATH) reached $12.83 at the closing of the latest trading day, reflecting a -1.16% change compared to its last close.
6 days ago · businesswire.com
UiPath Accelerates Enterprise AI Transformation with Google Cloud's Gemini for HealthcareNEW YORK--(BUSINESS WIRE)--UiPath joins as a launch partner, enabling healthcare organizations to automate and run complex workflows with full governance.
11 days ago · businesswire.com
UiPath Named a Leader in Everest Group's 2026 Agentic Process Automation Platform and Full Suite APAP PEAK Matrix® AssessmentsNEW YORK--(BUSINESS WIRE)--UiPath has been named a Leader and Star Performer in the Everest Group Agentic Process Automation Platform and Full Suite APAP PEAK Matrix Assessment.
12 days ago · seekingalpha.com
UiPath: AI Disruption Fears Are Overshadowing A Profitable CompounderUiPath earns a Buy rating, trading at a discounted 17.43x non-GAAP FWD P/E versus sector median 21.36x, with robust ARR and profit growth. PATH leverages its deterministic automation base to drive agentic AI adoption, orchestration, and software testing, with AI ARR now over $250M and growing 50%+ YoY. Net retention improved to 109% in Q2 FY2027, with large customer growth and disciplined cost control supporting a 448 bps YoY increase in non-GAAP operating margin.
13 days ago · zacks.com
Is Most-Watched Stock UiPath, Inc. (PATH) Worth Betting on Now?UiPath (PATH) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
14 days ago · zacks.com
UiPath (PATH) Falls More Steeply Than Broader Market: What Investors Need to KnowIn the most recent trading session, UiPath (PATH) closed at $13.34, indicating a -2.84% shift from the previous trading day.
14 days ago · fool.com
UiPath vs. SentinelOne: Which Technology Stock Is a Better Buy for 2027?UiPath has successfully transitioned to profitability while expanding its orchestration platform for AI agents and robots. SentinelOne maintains high revenue growth as it scales its AI-powered cybersecurity platform across global enterprise customers.
19 days ago · zacks.com
Can UiPath's Rising ARR Drive Sustained Growth for PATH Stock?UiPath's ARR reaches $1.94 billion as enterprise demand for AI-driven automation grows, but competition and monetization challenges remain.
20 days ago · zacks.com
PATH or APP: Which AI-driven Tech Stock Should You Bet on?UiPath's expanding AI automation platform, improving profitability and lower valuation strengthen its case against AppLovin's faster-growing ad business.
Analyst Summary
Add to Watchlist
Select watchlists to add or remove PATH